Orient Europharma Co Ltd (ROCO:4120) Stock Price, Trades & News

Orient Europharma Co Ltd is a Taiwan-based company engaged in the wholesale of Western Pharmaceutical and Medical Devices. The firm also manufactures drugs and medicines, Beverages, Cleaning Preparations, Cosmetics, Medical Devices, and Other Food Products. Its products cover various therapeutic areas, including the central nervous system, cardiovascular, diabetes, allergy, cosmetics, and health supplements. The company's segments include: Western Pharma BU which includes manufacture and sale of pharmaceutical and cosmetic products; and Nutricare BU includes sale of various nutrition supplements and consumable healthcare products. It derives maximum revenue from Western Pharma BU segment. Geographically, it operates in Taiwan, China, and Southeast Asia.

Financial Strength

3/10

Name	Current	Vs Industry
Cash-To-Debt	0.65
Equity-to-Asset	0.52
Debt-to-Equity	0.52
Debt-to-EBITDA	-2780.13
Piotroski F-Score	5/9	0 1 2 3 4 5 6 7 8 9
Altman Z-Score	1.3	Distress Grey Safe
Beneish M-Score	-2.55	Manipulator Not Manipulator
WACC vs ROIC		WACC ROIC

Growth Rank

1/10

	Name	Current	Vs Industry		Vs History
	3-Year Revenue Growth Rate	-1
	3-Year EBITDA Growth Rate	73.4
	3-Year EPS without NRI Growth Rate	-21.5
	3-Year FCF Growth Rate	17.6
	3-Year Book Growth Rate	29

Momentum Rank

10/10

	Name	Current	Vs Industry		Vs History
	5-Day RSI	23.02
	9-Day RSI	32.12
	14-Day RSI	37.73
	3-1 Month Momentum %	-4.64
	6-1 Month Momentum %	2.73
	12-1 Month Momentum %	-19

Liquidity Ratio

	Name	Current	Vs Industry		Vs History
	Current Ratio	1.47
	Quick Ratio	1.1
	Cash Ratio	0.73
	Days Inventory	168.43
	Days Sales Outstanding	60.4
	Days Payable	36.85

Dividend & Buy Back

	Name	Current	Vs Industry		Vs History
	Dividend Yield %	9.09
	3-Year Dividend Growth Rate	5.6
	Forward Dividend Yield %	9.09
	5-Year Yield-on-Cost %	9.09
	Shareholder Yield %	36.13

Profitability Rank

4/10

	Name	Current	Vs Industry		Vs History
	Gross Margin %	48.69
	Operating Margin %	-6.5
	Net Margin %	-12.35
	EBITDA Margin %	-0.03
	FCF Margin %	-10.46
	OCF Margin %	-6.36
	ROE %	-9.45
	ROA %	-4.71
	ROIC %	-2.93
	3-Year ROIIC %	-15.26
	ROC (Joel Greenblatt) %	-3.94
	ROCE %	-2.21
	Years of Profitability over Past 10-Year	7

GF Value Rank

7/10

	Name	Current	Vs Industry		Vs History
	Shiller PE Ratio	34.55
	PS Ratio	0.84
	PB Ratio	0.62
	Price-to-Tangible-Book	0.62
	EV-to-EBIT	-28.37
	EV-to-EBITDA	-4800.23
	EV-to-Revenue	1.23
	EV-to-FCF	-11.74
	Price-to-GF-Value	0.99
	Price-to-Projected-FCF	5.17
	Price-to-Median-PS-Value	0.99
	Earnings Yield (Greenblatt) %	-3.52
	FCF Yield %	-12.37
	Forward Rate of Return (Yacktman) %	-31.03

GF Value™: NT$44.98

ROCO:4120

Warning Signs

Warning! GuruFocus detected 3 Severe warning signs with 4120. Try a 7-Day Free Trial to check it out.

Orient Europharma Co Ltd Filings

10-K10-QForm 4Others

	Filing Date	Document Date	Form
No Filing Data

Orient Europharma Co Ltd Stock Events

Financials Calendars

Event	Date	Price (NT$)
TWD 4.000000 Cash Dividend	2026-07-20	48.00 (-0.10%)
TWD 1.000000 Cash Dividend	2025-07-07	56.40 (-0.88%)
1.16:1 Stock Split	2010-07-28	51.03 (+2.07%)
1.14207:1 Stock Split	2009-08-13	52.23 (+3.28%)
1.0999:1 Stock Split	2008-07-29	36.85 (+4.68%)
1.09865:1 Stock Split	2007-09-12	--
1.03:1 Stock Split	2006-07-19	--
1.01:1 Stock Split	2005-09-09	--
1.03:1 Stock Split	2004-07-29	--
1.05:1 Stock Split	2003-08-02	--

Show

Entries

Press Release

	Subject	Date
No Press Release

Articles on Orient Europharma Co Ltd

No articles.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.